RPRX – Royalty Pharma plc
Royalty Pharma plcRPRX
$31.03Name : Royalty Pharma plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $17,887,336,448.00
EPSttm : 1.91
Royalty Pharma plc
$31.03
0.26%$0.08Float Short %
4.66
Margin Of Safety %
46
Put/Call OI Ratio
0.34
EPS Next Q Diff
-0.14
EPS Last/This Y
2.75
EPS This/Next Y
0.31
Price
31.12
Target Price
41
Analyst Recom
1.44
Performance Q
20.63
Relative Volume
1.57
Beta
0.47
Ticker: RPRX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-10 | RPRX | 32.75 | 0.08 | 0.07 | 32998 |
| 2025-03-11 | RPRX | 32.47 | 0.08 | 0.09 | 33280 |
| 2025-03-12 | RPRX | 32.85 | 0.08 | 0.09 | 33281 |
| 2025-03-13 | RPRX | 32.69 | 0.08 | 0.62 | 33255 |
| 2025-03-14 | RPRX | 32.76 | 0.08 | 0.13 | 33614 |
| 2025-03-17 | RPRX | 33.01 | 0.08 | 0.43 | 33616 |
| 2025-03-18 | RPRX | 33.43 | 0.08 | 0.01 | 33654 |
| 2025-03-19 | RPRX | 33.42 | 0.08 | 0.00 | 33954 |
| 2025-03-20 | RPRX | 33.51 | 0.08 | 0.00 | 33979 |
| 2025-03-21 | RPRX | 33.69 | 0.08 | 0.00 | 33996 |
| 2025-03-24 | RPRX | 33.73 | 0.08 | 0.01 | 31707 |
| 2025-03-25 | RPRX | 33.7 | 0.08 | 29.22 | 31730 |
| 2025-03-26 | RPRX | 31.54 | 0.24 | 0.88 | 36277 |
| 2025-03-27 | RPRX | 31.65 | 0.26 | 3.73 | 41547 |
| 2025-03-28 | RPRX | 31.39 | 0.32 | 3.67 | 42749 |
| 2025-03-31 | RPRX | 31.12 | 0.34 | 2.47 | 43646 |
| 2025-04-01 | RPRX | 31.18 | 0.35 | 10.34 | 43976 |
| 2025-04-02 | RPRX | 31.28 | 0.37 | 23.15 | 44448 |
| 2025-04-03 | RPRX | 31.79 | 0.35 | 6.34 | 43956 |
| 2025-04-04 | RPRX | 31.11 | 0.34 | 15.51 | 43556 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-10 | RPRX | 32.74 | 9.1 | 538.7 | 4.70 |
| 2025-03-11 | RPRX | 32.47 | 9.1 | 538.7 | 4.70 |
| 2025-03-12 | RPRX | 32.85 | 9.1 | 569.0 | 4.70 |
| 2025-03-13 | RPRX | 32.68 | 9.1 | 543.2 | 4.70 |
| 2025-03-14 | RPRX | 32.77 | 8.3 | 555.1 | 4.67 |
| 2025-03-17 | RPRX | 33.02 | 8.3 | 562.8 | 4.67 |
| 2025-03-18 | RPRX | 33.41 | 8.3 | 569.1 | 4.67 |
| 2025-03-19 | RPRX | 33.41 | 8.3 | 551.9 | 4.67 |
| 2025-03-20 | RPRX | 33.50 | 8.3 | 555.0 | 4.67 |
| 2025-03-21 | RPRX | 33.69 | 8.3 | 559.7 | 4.67 |
| 2025-03-24 | RPRX | 33.75 | 8.3 | 553.4 | 4.67 |
| 2025-03-25 | RPRX | 33.76 | 8.3 | 551.4 | 4.67 |
| 2025-03-26 | RPRX | 31.56 | 8.3 | 452.9 | 4.67 |
| 2025-03-27 | RPRX | 31.64 | 8.3 | 554.7 | 4.67 |
| 2025-03-28 | RPRX | 31.37 | 8.3 | 537.8 | 4.67 |
| 2025-03-31 | RPRX | 31.13 | 8.3 | 539.7 | 4.67 |
| 2025-04-01 | RPRX | 31.17 | 8.3 | 553.3 | 4.67 |
| 2025-04-02 | RPRX | 31.28 | 8.3 | 556.1 | 4.67 |
| 2025-04-03 | RPRX | 31.79 | 8.3 | 574.9 | 4.67 |
| 2025-04-04 | RPRX | 31.12 | 8.3 | 519.8 | 4.67 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-10 | RPRX | 0.00 | 1.32 | 4.54 |
| 2025-03-11 | RPRX | 0.00 | 1.32 | 4.54 |
| 2025-03-12 | RPRX | 0.00 | 1.32 | 4.08 |
| 2025-03-13 | RPRX | 0.00 | 1.32 | 4.08 |
| 2025-03-14 | RPRX | 0.00 | 1.32 | 4.08 |
| 2025-03-17 | RPRX | 0.00 | 1.33 | 4.11 |
| 2025-03-18 | RPRX | 0.00 | 1.33 | 4.11 |
| 2025-03-19 | RPRX | 0.00 | 1.33 | 4.11 |
| 2025-03-20 | RPRX | 0.00 | 1.33 | 4.11 |
| 2025-03-21 | RPRX | 0.00 | 1.33 | 4.11 |
| 2025-03-24 | RPRX | 0.00 | 1.36 | 4.11 |
| 2025-03-25 | RPRX | 0.00 | 1.36 | 4.11 |
| 2025-03-26 | RPRX | 0.00 | 1.36 | 4.66 |
| 2025-03-27 | RPRX | 0.00 | 1.36 | 4.66 |
| 2025-03-28 | RPRX | 0.00 | 1.36 | 4.66 |
| 2025-03-31 | RPRX | 0.00 | 1.37 | 4.66 |
| 2025-04-01 | RPRX | 0.00 | 1.37 | 4.66 |
| 2025-04-02 | RPRX | 0.00 | 1.37 | 4.66 |
| 2025-04-03 | RPRX | 0.00 | 1.37 | 4.66 |
| 2025-04-04 | RPRX | 0.00 | 1.37 | 4.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.15
Avg. EPS Est. Current Quarter
1.06
Avg. EPS Est. Next Quarter
1.01
Insider Transactions
Institutional Transactions
1.37
Beta
0.47
Average Sales Estimate Current Quarter
724
Average Sales Estimate Next Quarter
657
Fair Value
45.54
Quality Score
69
Growth Score
52
Sentiment Score
83
Actual DrawDown %
44.9
Max Drawdown 5-Year %
Target Price
41
P/E
16.22
Forward P/E
5.92
PEG
1.27
P/S
7.92
P/B
2
P/Free Cash Flow
6.42
EPS
1.92
Average EPS Est. Cur. Y
4.67
EPS Next Y. (Est.)
4.98
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
37.93
Relative Volume
1.57
Return on Equity vs Sector %
-7.4
Return on Equity vs Industry %
5.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.46
EBIT Estimation
519.8
Royalty Pharma plcSector: Healthcare
Industry: Biotechnology
Employees:
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading